We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
BASEL, Switzerland Strong demand for cancer medicines and the antiviral drug Tamiflu helped increase Roche Holding's first-quarter sales by 22 percent, the Swiss pharmaceutical company said Wednesday.
NPS Pharmaceuticals, Inc. and its partner Nycomed announced today that the European Commission has granted marketing authorization for Preotact (parathyroid hormone [rDNA origin] for injection).
The UK has provided Kenya with $170 million worth of funding for first-line antiretroviral (ARV) drugs and HIV testing kits, according to the Department for International Development (DFID) -- the part of the British government that manages the country's aid to developing countries.
Ondansetron, an antiemetic -- a type of drug that combats vomiting and nausea -- can help improve outcomes in children with gastroenteritis, according to an article published in the New England Journal of Medicine (NEJM).
Dual endothelin receptor antagonist bosentan, which is known to be safe and effective in adults with pulmonary hypertension (PH), has also been shown to help pediatric PH patients, according to a study published in the British medical journal Heart.
China- and U.S.-based American Oriental Bioengineering (AOB) has acquired Chinese drugmaker Guangxi Lingfeng Pharmaceutical (GLP), which specializes in the manufacturing and distribution of plant-based medicines, the company announced.
Progress in developing an effective anti-HIV microbicide was far too slow, delegates attending the international microbicide conference in Cape Town, South Africa, heard this week.
Rexahn, a clinical stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer and disorders of the central nervous system, announced today that it has executed definitive agreements with Future Systems, Inc. (FSI), a Korean stock exchange (KOSDAQ) listed information technology company based in Seoul, Korea, which will be expanding its business to the biopharmaceutical industry.
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc., announced today that AMITIZA (lubiprostone), 24-mcg soft-gel capsules, approved by the U.S. Food and Drug Administration (FDA) in January 2006, is now available by prescription in pharmacies across the United States for the treatment of chronic idiopathic constipation in adults.